Study Stopped
PI leaving University
Early Palliative Care Integration in Interventional Cancer Care
EPIICC
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
A mixed methods randomized control trial assessing the impact of early palliative care incorporation in liver cancer and metastatic colorectal cancer on caregiver well-being, patient physical and psychosocial outcomes, and health services utilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2018
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2017
CompletedFirst Posted
Study publicly available on registry
June 14, 2017
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedApril 9, 2018
April 1, 2018
1 year
April 27, 2017
April 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Edmonton Symptom Assessment Score (ESAS-R)
Measure the impact of an early palliative care intervention on patient physical and psychosocial outcomes. The early integration of palliative care at diagnosis or immediately post- procedure, will improve patients' physical and psychosocial symptoms. The score of such assessment should decrease from baseline as the result of the intervention.
1, 2 and 3 months
Secondary Outcomes (1)
Measure of the Eastern Cooperative Oncology Group (ECOG) performance Status
1, 2 and 3 months
Other Outcomes (5)
Caregiver Well-being Scale
1, 2 and 3 months
Caregiver Quality of Life-Cancer Scale
1, 2 and 3 months
Measure the decrease in the score of the Center for Epidemiologic Studies Depression Scale (CES-D).
1, 2 and 3 months
- +2 more other outcomes
Study Arms (2)
Control group
NO INTERVENTIONThe first prospective group -the control group- will consist of 30 patients receiving treatment by the Interventional Radiology team- along with their 30 primary caregivers. Neither the patient nor the caregiver will receive the palliative care training intervention. Patients and their caregivers will receive questionnaires regarding their health status (physical and psychosocial) and health services utilization at 1, 2, and 3 months post-procedure- during their follow-up visits.
Intervention Group
EXPERIMENTALThe second prospective component of the study -the intervention group- will include 30 patients receiving treatment by the Interventional Radiology team along with their primary caregiver. Patients and caregivers will receive a brief palliative care training intervention during their first follow-up visit. Patients and their caregivers will receive questionnaires to assess their health status (physical and psychosocial) and health services utilization outcomes at 1, 2, and 3 months post-procedure during their follow-up visits.
Interventions
The intervention group- will include 30 patients receiving treatment by the Interventional Radiology team along with their primary caregiver. Patients and caregivers will receive a brief palliative care training intervention during their first follow-up visit. Patients and their caregivers will receive questionnaires to assess their health status (physical and psychosocial) and health services utilization outcomes at 1, 2, and 3 months post-procedure during their follow-up visits.
Eligibility Criteria
You may qualify if:
- \- Patients over 18 years of age with a confirmed diagnosis of liver cancer or metastatic colorectal cancer requiring treatment from the IR team.
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana M Echenique, MD
Univeristy of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Clinical, Vascular Interventional
Study Record Dates
First Submitted
April 27, 2017
First Posted
June 14, 2017
Study Start
August 1, 2018
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
April 9, 2018
Record last verified: 2018-04